The Mets' $40 million man, Jorge Polanco, is finally back on the field, marking a significant moment in the team's season. Polanco's return comes after a long and arduous journey through the injured list, where he battled Achilles issues and bursitis, with a brief detour to the Minor Leagues. This comeback is a testament to his resilience and the team's strategic decision-making.
A Power-Hitting DH
Polanco's power stroke was the primary reason the Mets signed him, and it's a key factor in his return. Despite his inability to play defense, his bat is a valuable asset. The team's interim manager, Andy Green, emphasizes the excitement surrounding Polanco's hitting prowess, suggesting that his bat is currently the most valuable contribution he can make.
A Journey of Pain Management
Polanco's journey has been one of managing pain and discomfort. He dealt with Achilles issues and bursitis, which required careful management. The team even considered surgery, which would have sidelined him for the rest of the season. However, Polanco's recent improvement in good days has allowed him to return to the Majors, marking a significant step forward in his recovery.
Impact on the Roster
Polanco's return will have a ripple effect on the team's lineup and strategy. He will not start every day at DH but will still contribute significantly. The team will need to manage his playing time, especially with catchers Francisco Alvarez and Luis Torrens, who have been utilizing the DH spot. Juan Soto and Francisco Lindor will also benefit from the DH role, allowing for strategic lineup adjustments.
First Base and Beyond
Polanco's future role is an interesting one. He may see time at first base, a position he will practice pregame. However, his ability to return to the infield will depend on his health and the team's needs. Jared Young and Mark Vientos have been platooning at first base, but their offensive and defensive performances have been underwhelming. Polanco's return could provide a much-needed boost to the team's performance at this position.
A Long-Term Investment
The Mets' investment in Polanco is a long-term one, with his contract extending through 2027. Green expresses excitement about Polanco's role as a designated hitter, highlighting his recent successful rehab games and home runs. This return is a significant step in the team's rebuilding process, and Polanco's presence will undoubtedly impact the team's performance and future prospects.
